Patents by Inventor Chiemi Minoda

Chiemi Minoda has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • High affinity anti-N,N-diacetylspermine monoclonal antibody
    Patent number: 7700741
    Abstract: The present invention provides an anti-diacetylspermine specific monoclonal antibody which satisfies a specific measuring condition in an immunoreaction system between a solid-phased diacetylspermine and the anti-diacetylspermine specific monoclonal antibody, wherein the immunoreaction system comprises a sample diacetylspermine or sample N1-acetylspermidine to inhibit the immunoreaction; and the specific measuring condition is that the 50% inhibition activity against the immunoreaction by the diacetylspermine in the sample is at least 1,000 times as much as the 50% inhibition activity against the immunoreaction by the N1-acetylspermidine in the sample.
    Type: Grant
    Filed: October 31, 2005
    Date of Patent: April 20, 2010
    Assignee: Trans Genic Inc.
    Inventors: Yusei Nagase, Shingo Shinagawa, Masao Kawakita, Kyoko Hiramatsu, Mika Ito, Yosuke Mizukami, Chiemi Minoda
  • HIGH AFFINITY ANTI-N1,N12-DIACETYLSPERMINE MONOCLONAL ANTIBODY
    Publication number: 20100093006
    Abstract: The present invention provides an anti-diacetylspermine specific monoclonal antibody which satisfies a specific measuring condition in an immunoreaction system between a solid-phased diacetylspermine and the anti-diacetylspermine specific monoclonal antibody, wherein the immunoreaction system comprises a sample diacetylspermine or sample N1-acetylspermidine to inhibit the immunoreaction; and the specific measuring condition is that the 50% inhibition activity against the immunoreaction by the diacetylspermine in the sample is at least 1,000 times as much as the 50% inhibition activity against the immunoreaction by the N1-acetylspermidine in the sample.
    Type: Application
    Filed: October 13, 2009
    Publication date: April 15, 2010
    Inventors: Yusei Nagase, Shingo Shinagawa, Masao Kawakita, Kyoko Hiramatsu, Mika Ito, Yosuke Mizukami, Chiemi Minoda
  • Anti-HIV antibody
    Patent number: 7667006
    Abstract: The present invention aims at providing a high affinity anti-HIV antibody. According to the present invention, there are provided an antibody or a fragment thereof that binds to the gp12 glycoprotein of HIV and has a dissociation constant (KD) value of 1.0×10?9 (M) or less; a pharmaceutical composition comprising the antibody or fragment thereof; and a method of producing an anti-HIV antibody or a fragment thereof, comprising immunizing a GANP transgenic non-human mammal or a progeny thereof with a polypeptide consisting of the amino acid sequence as shown in SEQ ID NO: 6 as an antigen and collecting the antibody from the resultant mammal or progeny.
    Type: Grant
    Filed: March 9, 2004
    Date of Patent: February 23, 2010
    Assignee: Kumamoto Technology and Industry Foundation
    Inventors: Nobuo Sakaguchi, Kazuhiko Kuwahara, Chiemi Minoda
  • Anti-Hiv Antibody
    Publication number: 20080050365
    Abstract: The present invention aims at providing a high affinity anti-HIV antibody. According to the present invention, there are provided an antibody or a fragment thereof that binds to the gp12 glycoprotein of HIV and has a dissociation constant (KD) value of 1.
    Type: Application
    Filed: March 9, 2004
    Publication date: February 28, 2008
    Applicant: Kumamoto Technology and Industry Foundation
    Inventors: Nobuo Sakaguchi, Kazuhiko Kuwahara, Chiemi Minoda
  • High affinity anti-N¹,N¹²-diacetylspermine monoclonal antibody
    Publication number: 20060166297
    Abstract: The present invention provides an anti-diacetylspermine specific monoclonal antibody which satisfies a specific measuring condition in an immunoreaction system between a solid-phased diacetylspermine and the anti-diacetylspermine specific monoclonal antibody, wherein the immunoreaction system comprises a sample diacetylspermine or sample N1-acetylspermidine to inhibit the immunoreaction; and the specific measuring condition is that the 50% inhibition activity against the immunoreaction by the diacetylspermine in the sample is at least 1,000 times as much as the 50% inhibition activity against the immunoreaction by the N1-acetylspermidine in the sample.
    Type: Application
    Filed: October 31, 2005
    Publication date: July 27, 2006
    Inventors: Yusei Nagase, Shingo Shinagawa, Masao Kawakita, Kyoko Hiramatsu, Mika Ito, Yosuke Mizukami, Chiemi Minoda